CELLINI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 4.039
EU - Europa 3.207
AS - Asia 2.813
SA - Sud America 328
AF - Africa 44
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.443
Nazione #
US - Stati Uniti d'America 3.965
CN - Cina 1.180
RU - Federazione Russa 1.119
GB - Regno Unito 967
SG - Singapore 903
BR - Brasile 272
VN - Vietnam 244
IT - Italia 217
HK - Hong Kong 202
SE - Svezia 187
FR - Francia 164
FI - Finlandia 144
IE - Irlanda 138
DE - Germania 130
KR - Corea 81
CA - Canada 44
UA - Ucraina 43
JP - Giappone 42
BD - Bangladesh 35
IN - India 25
BE - Belgio 24
NL - Olanda 17
IQ - Iraq 16
MX - Messico 16
ID - Indonesia 15
PL - Polonia 15
AR - Argentina 14
TR - Turchia 13
ZA - Sudafrica 13
NG - Nigeria 12
PK - Pakistan 12
EC - Ecuador 11
ES - Italia 8
UZ - Uzbekistan 8
VE - Venezuela 8
SA - Arabia Saudita 7
AT - Austria 6
AU - Australia 6
CL - Cile 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
LT - Lituania 5
MA - Marocco 5
UY - Uruguay 5
PT - Portogallo 4
TN - Tunisia 4
AZ - Azerbaigian 3
CH - Svizzera 3
GR - Grecia 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
EU - Europa 2
JM - Giamaica 2
JO - Giordania 2
KW - Kuwait 2
MY - Malesia 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
AM - Armenia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GF - Guiana Francese 1
GL - Groenlandia 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.443
Città #
Southend 863
Dallas 588
Singapore 471
Ashburn 382
Moscow 361
San Jose 357
Jacksonville 325
Chandler 323
Ann Arbor 271
Woodbridge 261
Hong Kong 197
Beijing 192
Houston 159
Verona 140
Dublin 137
The Dalles 109
Jinan 93
Ho Chi Minh City 89
Shenyang 83
Nanjing 77
Wilmington 74
Council Bluffs 69
Los Angeles 59
Lawrence 58
New York 58
Princeton 58
Hanoi 51
Tianjin 51
Hebei 45
Tokyo 39
Columbus 36
Ningbo 35
Changsha 34
Helsinki 34
Zhengzhou 33
Nanchang 32
Buffalo 30
São Paulo 30
Haikou 29
Santa Clara 27
Seattle 25
Seoul 25
Milan 24
Brussels 23
Hangzhou 23
Lanzhou 23
Munich 22
Taiyuan 22
Jiaxing 21
Taizhou 21
San Francisco 20
Montreal 18
Boardman 17
Fuzhou 17
Guangzhou 17
Brooklyn 15
Falls Church 13
Orem 13
Redondo Beach 13
Toronto 13
Lancaster 12
London 12
Warsaw 12
Belo Horizonte 11
Boston 11
Da Nang 11
Denver 11
Sindelfingen 11
Abuja 10
Chennai 10
Chicago 10
Jakarta 10
Norwalk 10
Redwood City 10
Johannesburg 9
Elora 8
Frankfurt am Main 8
Kent 8
Mexico City 8
Perugia 8
Rio de Janeiro 8
Tashkent 8
Amsterdam 7
Auburn Hills 7
Birmingham 7
Dong Ket 7
Atlanta 6
Dearborn 6
Haiphong 6
Kemerovo 6
Phoenix 6
Hải Dương 5
Manchester 5
Redmond 5
Shanghai 5
Stockholm 5
Vienna 5
Baghdad 4
Cambridge 4
Can Tho 4
Totale 7.061
Nome #
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 303
Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria 298
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 283
Holo-and apocystalysin from Treponema denticola: two different conformations 270
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 262
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 253
Characterization of C-S Lyase from C. diphtheriae: A Possible Target for New Antimicrobial Drugs 241
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 233
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 227
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 225
S-Glutathionylation at Cys328 and Cys542 Impairs STAT3 Phosphorylation 216
Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T 215
Astrocytes regulate the expression of Insulin-Like Growth Factor 1 Receptor (IGF1-R) in primary cortical neurons during in vitro senescence 215
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 206
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 204
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 202
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 202
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 199
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 199
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 196
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 194
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 192
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 190
Oligomeric state and thermal stability of apo- and holo- human ornithine δ-aminotransferase 190
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 189
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 181
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 181
PLP-Dependent Enzymes 178
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 176
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 173
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 173
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 171
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 168
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 165
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 161
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 157
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 156
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 155
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 154
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 153
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 151
Rapid profiling of disease alleles using a tunable reporter of protein misfolding 150
Radiation damage at the active site of human alanine:glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis 150
Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells 143
Role of N-acetyilaspartate (NAA) and N-acetyl-aspartyl-glutamate (NAAG) in early stage of pilocarpine induced status epilepticus in rat 143
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 143
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 135
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 134
Molecular and biochemical methods to assess the biological impact of Quantum Dots 133
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 131
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 130
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 128
Molecular insights into primary hyperoxaluria Type I pathogenesis. 125
Intracellular ascorbic acid enhances the DNA single-strand and toxicity induced by peroxynitrite in U937 cells 122
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 122
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 121
Treponema denticola cystalysin exhibits a significant alanine racemase activity accompanied by transamination: mechanistic implications 118
Targeting Cystalysin, a Virulence Factor ofTreponema denticola-Supported Periodontitis 115
Totale 10.500
Categoria #
all - tutte 32.437
article - articoli 30.509
book - libri 0
conference - conferenze 1.435
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 493
Totale 64.874


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022711 60 250 102 31 19 13 9 41 23 10 29 124
2022/2023988 77 110 83 168 93 228 22 53 118 4 16 16
2023/2024406 23 35 22 44 36 66 6 32 3 27 84 28
2024/20251.335 67 85 16 215 65 49 100 43 221 105 121 248
2025/20264.220 284 190 613 511 950 317 402 200 301 263 79 110
Totale 10.500